EU launches legal action against AstraZeneca

Published April 27, 2021
MILAN: People eat lunch at the terrace of a restaurant by a canal as much of Italy saw easing of coronavirus restrictions on Monday.—Reuters
MILAN: People eat lunch at the terrace of a restaurant by a canal as much of Italy saw easing of coronavirus restrictions on Monday.—Reuters

BRUSSELS: The European Union’s executive branch said on Monday that it has launched legal action against coronavirus vaccine-maker AstraZeneca for failing to respect the terms of its contract with the 27-nation bloc.

The AstraZeneca vaccine has been central to Europe’s immunisation campaign, and a linchpin in the global strategy to get vaccines to poorer countries. But the slow pace of deliveries has frustrated the Europeans and they have held the company responsible for partly delaying their vaccine rollout.

European Commission spokesman Stefan De Keersmaecker said that Brussels launched the legal action against AstraZeneca on the basis of breaches of the advance purchase agreement.

He said the reason for the legal action was that some terms of the contract have not been respected and that the company has not been in a position to come up with a reliable strategy to ensure a timely delivery of doses.

AstraZeneca’s contract with the EU, which was signed by the Commission on behalf of the member countries last August, foresaw an initial 300 million doses for distribution among member countries, with an option for a further 100 million.

The British-Swedish drugmaker had hoped to deliver 80 million doses of that in the first quarter of 2021, but only 30 million were sent. According to the Commission, the company is now set to provide 70 million doses in the second quarter, rather than the 180 million it had promised.

AstraZeneca said in a statement that it regrets the Commission’s decision to take legal action and that it will strongly defend itself in court.

We believe any litigation is without merit and we welcome this opportunity to resolve this dispute as soon as possible, AstraZeneca said. It said deliveries are improving following an unprecedented year of scientific discovery, very complex negotiations, and manufacturing challenges.

We are making progress addressing the technical challenges and our output is improving, but the production cycle of a vaccine is very long which means these improvements take time to result in increased finished vaccine doses, it said.

The company said it wants to continue working constructively with the EU Commission to vaccinate as many people as possible. Many thousands of our employees working around the clock have been driven by a passion to help the world at no profit.

The AstraZeneca vaccine is cheaper and easier to use than rival shots from Pfizer and Moderna and has been endorsed for use in over 50 countries, including by the 27-nation EU and the World Health Organisation. US authorities are still evaluating the vaccine.

The Commission has publicly criticised the company on several occasions, and last month it launched a dispute resolution mechanism aimed at amicably addressing their differences. Brussels said that its focus is to ensure timely deliveries of vaccines.

Published in Dawn, April 27th, 2021

Opinion

Last call
Updated 23 Sep 2021

Last call

The exchange rate alone can no longer absorb the full impact of the deterioration in the current account.
Appeasing terrorists
Updated 22 Sep 2021

Appeasing terrorists

The policy of appeasement has not worked in the past and it certainly will not work now.

Editorial

Dialogue, at last
Updated 23 Sep 2021

Dialogue, at last

The govt has attempted to make the ECP controversial at a time when its input is critical for the poll reforms
AUKUS controversy
Updated 23 Sep 2021

AUKUS controversy

Instead of flexing its military muscle, the Western bloc needs to engage China at the negotiating table.
Provocative act
Updated 23 Sep 2021

Provocative act

Afghan Taliban flags have been found hoisted at Jamia Hafsa seminary three times since Aug 21.
22 Sep 2021

Interest rate hike

THE State Bank’s decision to raise its key interest rate by 25bps to 7.25pc underpins its acceptance of emerging...
PCB chief’s challenge
Updated 22 Sep 2021

PCB chief’s challenge

The Taliban takeover of Afghanistan has propelled fears of regional insecurity.
22 Sep 2021

No need for secrecy

THE government should not make a mountain out of the Toshakhana molehill. That would only encourage speculation of...